Bionik Laboratories (OTCMKTS:BNKL) versus ClearPoint Neuro (NASDAQ:CLPT) Critical Review

Bionik Laboratories (OTCMKTS:BNKL) and ClearPoint Neuro (NASDAQ:CLPT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Insider & Institutional Ownership

30.1% of ClearPoint Neuro shares are held by institutional investors. 34.7% of Bionik Laboratories shares are held by company insiders. Comparatively, 7.0% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

Bionik Laboratories has a beta of -1.69, meaning that its stock price is 269% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500.

Profitability

This table compares Bionik Laboratories and ClearPoint Neuro’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bionik Laboratories	N/A	N/A	N/A
ClearPoint Neuro	-67.40%	-114.28%	-48.09%

Valuation & Earnings

This table compares Bionik Laboratories and ClearPoint Neuro”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bionik Laboratories	$1.80 million	N/A	-$4.95 million	($0.38)	N/A
ClearPoint Neuro	$31.39 million	13.51	-$18.91 million	($0.84)	-17.76

Bionik Laboratories has higher earnings, but lower revenue than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Bionik Laboratories, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Bionik Laboratories and ClearPoint Neuro, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bionik Laboratories	0	0	0	0	0.00
ClearPoint Neuro	1	0	3	0	2.50

ClearPoint Neuro has a consensus target price of $19.67, indicating a potential upside of 31.81%. Given ClearPoint Neuro’s stronger consensus rating and higher possible upside, analysts plainly believe ClearPoint Neuro is more favorable than Bionik Laboratories.

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

About ClearPoint Neuro

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.